  HBV genotype  HBV subgenotype  References 
 Morocco  D (97.5%), A (2.5%)   [16]  D (100%)   [18, 23]  D (90.45%), A (5.9%), E (0.5%), and mixed (A/D and D/F) (3.17%)  D7 (63.3%), D1 (32.7%), D4 (2%), D5 (2%), and A2  [24] 
 Algeria  D (93%), A (5%), and E (2%)   [34]  D (86.5%) and A (11.76%)  D7 (43.5%), D3 (24.75%), D1 (16.8%), D2 (14.85%), and A2 (11.76%)  [35] 
 Tunisia  D (80%), A (9%), and E (8%)  D7  [40]  D (84.75%), A (0.6%), B (0.6%), C (1.82%), and 20 mixed genotypes (12.2%)   [41]  D (96%), A (4%)  D1 (55%), D7 (41%), and D3 (3%)  [42] 
 Libya  D (90%), A (1.7%), E (1.7%), and D/E (6.7%)  ND  [51] 
 Egypt  D (100%)   [58]  D (87%) and mixed D/F (13%)   [59]  E (50%), D (21.43%), and coinfection D/E (28.57%)  D1 (21.43%)  [57]  D (37.1%) and B (25.7%)   [61] 
 Syria  D (97%)  ND  [67]  D (100%)   [68] 
 Lebanon  D (100%)  D1 (57.38%) and D2 (11.48%)  [72] 
 Palestine/Israel  HBV/HDV: D (100%)  D2 (66.7%), D1 (16.7%), and D3 (16.7%)  [75]  HBV: D (88.9%), A (7.4%), and C (3.7%)  D1 (59.3%), D2 (18.5%), D3 (11.1%), and A1, A2, and C2 (3.7%)   D (92.5%) and A (7.5%)  D1 (90%), D3 (2.5%), and A2 (7.5%)  [76] 
 France  G  ND  [84]  D (29%), A (24%), C (11%), and E (10%)   [85]  D (27%), A (24%), E (13%), C (12%), B (7%), and mixed genotypes (16%)   [86] 
 Spain  A (52%), D (35%), and F (7%)  D4 (59%), D2 (30%), D3 (7%), and D1 (4%)  [94]  D (64.6%)   [95] 
 Italy  D (95%)   [107]  D (90%)   [108]  D (53%), A (44%), and E (3%)  D2  [109]  D (49%), A (45%), and F (6%)   [110] 
 Turkey  D (93.04%)  D2 (94.6%), D1 (3.9%), and D2+deletion (1.5%)  [117]  D (88.7%)  D2 (78%85.9%), D2+deletion (8.9%), D1 (3.9%) and (1.3%)  [118]  D (100%)   [119]  D (99.1%)   [115] 
 Greece  D (100%)  ND  [125]  D (98%), A (1%), B (0.5%), and C (0.5%)   [126] 
 Croatia  D (80%), A (8%), and mixed genotypes 12%  ND  [132] 

